We are a national laboratory and Federally Funded Research and Development Center dedicated to the application of biomedical science and technology to improve human health.
Our scientists conduct basic, translational and applied research, create new technologies, and collaborate with government, industry and academic colleagues. We support the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and other institutes within the National Institutes of Health.
As a government-owned, contractor-operated scientific enterprise, the Frederick National Laboratory for Cancer Research efficiently addresses critical biomedical questions that no one else can readily do, and rapidly responds to emerging health threats.
- Biomedical research institute focusing on cancer, HIV/AIDS and infectious diseases
- National resource for the scientific community
- One of 42 Federally Funded Research and Development Centers, designated private-public partnerships with the U.S. government
- The only one of 18 national laboratories dedicated to biomedical sciences
- Sponsored by the National Cancer Institute
Advancing cutting-edge science
From nanotechnology to genotyping to bioinformatics, FNL scientists advance biomedical research across disciplines, often leveraging cutting-edge tools and techniques.
Innovating research technology
Our scientists explore new ways to improve existing research technology and to make cutting-edge tools more accessible.
Supporting clinical trials
FNL supports the management of clinical trials worldwide, helping to quickly launch critical clinical studies amid health emergencies such as the Ebola virus disease outbreak in West Africa and the worldwide COVID-19 pandemic.
Partnering in biomedical research endeavors
We collaborate through partnerships and subcontracts to advance the biomedical sciences, from our local community to global organizations.
Developing vaccines & biological products
We have facilities that develop and manufacture investigational vaccines and biopharmaceutical products in support of clinical trials for cancer, HIV/AIDS, rare diseases, and infectious diseases.
Investigating disease mechanisms and possible treatments
Our scientists study critical diseases such as cancer and HIV/AIDS to better understand how they work to find ways to better diagnose, prevent, and treat them.
Studying the efficacy of drugs and vaccines
Teams across FNL evaluate the efficacy of drugs and vaccines in the prevention and treatment of diseases.
Creating & curating repositories
Our teams develop and manage various repositories as resources for researchers, from tumor cell lines to natural products to data commons.
